Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Broad neutralization coverage of HIV by multiple highly potent antibodies

Open access

Abstract

Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies. The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature10373

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. Plotkin, S. A. Orenstein, W. A. & Offit, P. A. Vaccines (Elsevier Health Sciences, Philadelphia, 2008)

Cited by

See all 1,480

Metadata

Authors
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., Mitcham, J. L., Hammond, P. W., Olsen, O. A., Phung, P., Fling, S., Wong, C.-H., Phogat, S., Wrin, T., Simek, M. D., Principal Investigators, P. G., Koff, W. C., Wilson, I. A., Burton, D. R., & Poignard, P.
Affiliations
  • Scripps Research Institute (US)
  • Theraclone Sciences (United States) (US)
  • International AIDS Vaccine Initiative (US)
Corresponding author
  • Burton, Dennis R.
  • Poignard, Pascal
Venue
Nature
Published
2011-09
Volume
477
Issue
7365
Pages
466-470
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2113236498
Cited by
1,480
References
32
Citations by year
2026: 35 · 2025: 46 · 2024: 51 · 2023: 54 · 2022: 69 · 2021: 81 · 2020: 82 · 2019: 92 · 2018: 107 · 2017: 134 · 2016: 109 · 2015: 144 · 2014: 154 · 2013: 157 · 2012: 139
FWCI
60.04
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI033292, R01AI084817)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
HIV, broadly neutralizing antibodies, monoclonal antibodies, antibody repertoire, gp120, envelope glycoprotein, neutralization breadth, HIV vaccine design, passive immunization, antibody-based vaccines
MeSH terms
Antibodies, Monoclonal, Epitopes, Cell Line, Glycoproteins, Glycosylation, HIV, Humans, Immune Sera, Molecular Sequence Data, Neutralization Tests, HIV Antibodies, HIV Infections, AIDS Vaccines, Epitope Mapping, Human Immunodeficiency Virus Proteins, Antibodies, Neutralizing, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Broad neutralization coverage of HIV by multiple highly potent antibodies. https://app.cochat.ai/papers/10.1038/nature10373
The paper
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., Mitcham, J. L., Hammond, P. W., Olsen, O. A., Phung, P., Fling, S., Wong, C.-H., Phogat, S., Wrin, T., Simek, M. D., . . . Poignard, P. (2011). Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature. https://doi.org/10.1038/nature10373

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.